- Home
- IART vs ORIC Comparison
IART vs ORIC Comparison
Compare IART & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IART
- ORIC
- Stock Information
- Founded
- IART 1989
- ORIC 2014
- Country
- IART United States
- ORIC United States
- Employees
- IART N/A
- ORIC N/A
- Industry
- IART Medical/Dental Instruments
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- IART Health Care
- ORIC Health Care
- Exchange
- IART Nasdaq
- ORIC Nasdaq
- Market Cap
- IART 1.1B
- ORIC 938.2M
- IPO Year
- IART 1995
- ORIC 2020
- Fundamental
- Price
- IART $14.86
- ORIC $9.74
- Analyst Decision
- IART Hold
- ORIC Strong Buy
- Analyst Count
- IART 8
- ORIC 9
- Target Price
- IART $18.17
- ORIC $17.25
- AVG Volume (30 Days)
- IART 1.5M
- ORIC 1.3M
- Earning Date
- IART 07-31-2025
- ORIC 08-12-2025
- Dividend Yield
- IART N/A
- ORIC N/A
- EPS Growth
- IART N/A
- ORIC N/A
- EPS
- IART N/A
- ORIC N/A
- Revenue
- IART $1,621,738,000.00
- ORIC N/A
- Revenue This Year
- IART $5.56
- ORIC N/A
- Revenue Next Year
- IART $4.41
- ORIC N/A
- P/E Ratio
- IART N/A
- ORIC N/A
- Revenue Growth
- IART 3.53
- ORIC N/A
- 52 Week Low
- IART $11.06
- ORIC $3.90
- 52 Week High
- IART $27.13
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- IART 61.72
- ORIC 46.26
- Support Level
- IART $13.65
- ORIC $9.32
- Resistance Level
- IART $14.94
- ORIC $10.06
- Average True Range (ATR)
- IART 0.66
- ORIC 0.48
- MACD
- IART 0.14
- ORIC -0.02
- Stochastic Oscillator
- IART 89.31
- ORIC 57.46
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.